|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/542 | (2006.01) |
| G01N 33/58 | (2006.01) | ||
| G01N 33/68 | (2006.01) | ||
| G01N 33/86 | (2006.01) |
| (11) | Patento numeris | 2431741 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11009919.9 |
| Europos patento paraiškos padavimo data | 2009-10-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-03-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-08-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 10725708 P | 2008-10-21 | US | |
| 24263409 P | 2009-09-15 | US |
| (72) |
Varadi, Katalin, AT
Schrenk, Gerald, AT
Rottensteiner, Hanspeter, AT
Turecek, Peter, AT
Weber, Alfred, AT
Anderle, Heinz, AT
Culbertson, Sean M., US
Fang, Zhihao, US
Zappe, Harold, US
Zhang, Ping, US
Bossard, Mary J., US
|
| (73) |
Baxter Healthcare SA,
Thurgauerstrasse 130, 8152 Glattpark (Opfikon),
CH
Baxter International Inc, One Baxter Parkway, Deerfield, IL 60015, US Nektar Therapeutics, 455 Mission Bay Boulevard South, Suite 100, San Francisco, CA 94158, US |
| (54) | Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation) |
| Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation) |